NxStage Founder and CEO Discusses Innovation in Healthcare at EY Boston Life Sciences Summit

Jeff Burbank provides insight on innovative growth opportunities within value-conscious medical device industry

News provided by

Dec 19, 2014, 08:00 ET

LAWRENCE, Mass., Dec. 19, 2014 /PRNewswire/ -- Jeff Burbank, CEO and Founder of NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, spoke on Monday, December 15, 2014 among a panel of Boston-based healthcare executives at the EY Life Sciences Summit in Boston. While highlighting NxStage's mission to pioneer the home hemodialysis market with its innovative System One™, the first and only portable home hemodialysis system cleared by the U.S. Food and Drug Administration (FDA), Burbank shared his perspective on the increasing significance of innovations that can improve the delivery of care.

Echoing a common theme in today's healthcare environment, Burbank agreed that today's breakthrough innovations require a clear economic value proposition that extends beyond clinical benefits. He added that today, NxStage is advancing this concept by providing customers with valuable integrated offerings aimed at improving care delivery. Burbank commented, "At NxStage, we are fortunate that the technology choices we made very early on have proven to be the right ones to expand our reach into other offerings that increase our value to customers. Our patients and customers have played an equally important role in helping us bring these innovations to market. We've learned a tremendous amount from interacting directly with thousands of patients over the past fourteen years. This experience is invaluable. Without their continued support and feedback, we could not bring breakthrough technology and solutions to the market."

Burbank stated, "We've worked hard to ensure that our entire business model is focused on improving the delivery of care- making our therapy easier to administer and manage for both customers and patients - whether through clinical work, product development, customer support, integrated offerings and services, training and education, or our market development initiatives. In turn, this innovative model is driving market adoption and unlocking tremendous growth opportunities in untapped areas for NxStage."

About NxStage Medical, Inc.
NxStage is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of ESRD and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at www.nxstage.com.

Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-Q for the quarter ended September 30, 2014. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

Media contact:
Kristen K. Sheppard, Esq.
Vice President, Investor Relations and Corporate Counsel
[email protected]

Logo - http://photos.prnewswire.com/prnh/20110503/MM94799LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nxstage-founder-and-ceo-discusses-innovation-in-healthcare-at-ey-boston-life-sciences-summit-300012275.html

SOURCE NxStage Medical Inc.